Industry

Biotechnology

Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.

Total Companies
1 341
Biotechnology Industry
Company Intrinsic Valuation Profitability Score Solvency Score Market Cap
Abbvie Inc
NYSE:ABBV
Loading...
10% Overvalued
72 / 100
43 / 100
$404.2B
Amgen Inc
NASDAQ:AMGN
Loading...
11% Overvalued
64 / 100
28 / 100
$178.1B
Gilead Sciences Inc
NASDAQ:GILD
Loading...
4% Overvalued
68 / 100
63 / 100
$154.7B
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Loading...
27% Overvalued
60 / 100
87 / 100
$117.2B
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Loading...
4% Overvalued
56 / 100
97 / 100
$82.6B
CSL Ltd
ASX:CSL
Loading...
23% Undervalued
55 / 100
63 / 100
$55.7B
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Loading...
26% Overvalued
50 / 100
48 / 100
$52.7B
argenx SE
XBRU:ARGX
Loading...
23% Overvalued
57 / 100
99 / 100
$51.8B
Insmed Inc
NASDAQ:INSM
Loading...
61% Overvalued
31 / 100
61 / 100
$37.9B
Beigene Ltd
SSE:688235
Loading...
22% Overvalued
38 / 100
75 / 100
$35B
Beigene Ltd
HKEX:6160
Loading...
14% Overvalued
38 / 100
75 / 100
$33.7B
Natera Inc
NASDAQ:NTRA
Loading...
60% Overvalued
29 / 100
71 / 100
$32.3B
Celltrion Inc
KRX:068270
Loading...
13% Overvalued
49 / 100
69 / 100
$27.2B
Biogen Inc
NASDAQ:BIIB
Loading...
10% Undervalued
54 / 100
64 / 100
$25.8B
BioNTech SE
NASDAQ:BNTX
Loading...
42% Overvalued
39 / 100
75 / 100
$22.7B
United Therapeutics Corp
NASDAQ:UTHR
Loading...
24% Overvalued
69 / 100
93 / 100
$21.9B
Genmab A/S
CSE:GMAB
Loading...
79% Overvalued
70 / 100
99 / 100
$20.6B
Incyte Corp
NASDAQ:INCY
Loading...
2% Undervalued
60 / 100
85 / 100
$19.6B
Exact Sciences Corp
NASDAQ:EXAS
Loading...
54% Overvalued
31 / 100
38 / 100
$19.3B
Innovent Biologics Inc
HKEX:1801
Loading...
23% Overvalued
46 / 100
81 / 100
$17.2B
Load More